Abstract
The effects of sulfasalazine and its moieties on synthesis of individual products of arachidonic acid metabolism by human colonic mucosa have been investigated. Sulfasalazine inhibited synthesis of the lipoxygenase products. Sulfasalazine and sulfapyridine also inhibited synthesis of thromboxane B2 while enhancing synthesis of prostaglandin (PG) F2α or PGE2, respectively. Inhibition of synthesis of lipoxygenase products and modulation of the profile of cyclooxygenase products could reduce inflammation and enhance mucosal resistance to damage in ulcerative colitis.
Similar content being viewed by others
References
Smith PR, Dawson DJ, Swan CHJ: Prostaglandin synthetase activity in active ulcerative colitis: Effects of treatment with sulfasalazine, codeine phosphate and prednisolone. Gut 20:802–805, 1978
Ligumsky M, Karmeli F, Sharon P, Zor U, Cohen F, Rachmilewitz PD: Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulphasalazine. Gastroenterology 81:444–449, 1981
Gilat T, Ratan J, Rosen P, Peled Y: Prostaglandins and ulcerative colitis. Gastroenterology 76:1083, 1979
Rampton DS, Sladen GE: Prostaglandin synthesis inhibitors in ulcerative colitis. Flurbiprofen compared with conventional treatment. Prostaglandins 21:417–425, 1981
Samuelsson B: Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–575, 1983
Palmer RMJ, Stepney R, Higgs GA, Eakins KE: Chemokinetic activity of arachidonic acid lipoxygenase products on leukocytes from different species. Prostaglandins 20:411–418, 1980
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH: Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leucocytes. Nature 286:264–265, 1980
Bennet A, Hensby CN, Sanger GJ, Stamford IF: Metabolites of arachidonic acid formed by human gastrointestinal tissue and their actions on the muscle layers. Br J Pharmacol 74:435–444, 1981
Boughton-Smith NK, Hawkey CJ, Whittle BJR: The biosynthesis of lipoxygenase and cyclooxygenase products from [14C]arachidonic acid by human colonic mucosa. Gut 24:1176–1182, 1983
Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453–460, 1984
Boughton-Smith NK, Hawkey CJ, Whittle BJR: Sulphasalazine and the inhibition of thromboxane synthesis in human colonic mucosa. Br J Pharmacol 80:605P, 1983
Peppercorn MA, Goldman P: Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 64:240–245, 1973
Azad Khan AK, Truelove SC, Aronson JK: The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 13:532–538, 1982
Sircar JC, Schwender CF, Carethers ME: Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis. Biochem Pharmacol 32:170–172, 1983
Stenson WF, Lobos E: Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 69:494–497, 1982
Molin L, Stendohl O: The effects of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis. Acta Med Scand 206:451–457, 1979
Rhodes JM, Bartholomew TC, Jewell DP: Inhibition of leucocyte motility by drugs used in ulcerative colitis. Gut 22:642–647, 1982
Stenson WF, Lobos E: Inhibition of platelet thromboxane synthetase by sulfasalazine. Biochem Pharmacol 32(14):2205–2209, 1983
Rachmilewitz D, Ligumsky M, Haimaritz A, Treves A: Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory disease of the bowel. Gastroenterology 82:673–679, 1982
Rask Madsen J, Bukhave K: Prostaglandins and chronic diarrhoea: Clinical aspects. Scand J Gastroenterol 14(Suppl 53):73–78, 1979
Whittle BJR, Vane JR: Prostacyclin, thromboxanes and prostaglandins—actions and roles in the gastrointestinal tract.In Progress in Gastroenterology, Vol 4. GB Jerzy-Glass, P Sherlock (eds). 1983, pp 3–29
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats—prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77:433–443, 1979
Miller TA, Jacobson ED: Gastrointestinal cytoprotection by prostaglandins. Gut 20:75–87, 1979
Hoult JRS, Moore PK: Sulphasalazine, a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: Possible basis for therapeutic action in ulcerative colitis. Br J Pharmacol 64:6–8, 1978
Hoult JRS, Page H: 5-Aminosalicylic acid, a cofactor for colonic prostacyclin synthesis? Lancet 2:225, 1981
Whittle BJR, Moncada S: The pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull 39:232–238, 1983
Lefer AM, Ogletree ML, Smith JB, Silver MJ, Nicolaou KC, Barnette WE, Gasic GP: Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 200:52–54, 1978
Stachura J, Tarnawski A, Ivey K, Mach T, Bogdal J, Szczudrawa J, Klimczyk B: Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81:211–217, 1981
Whittle BJR, Kauffman GL, Moncada S: Vasoconstriction and thromboxane A2 induces ulceration of the gastric mucosa. Nature 292:472–474, 1980
Azad Khan AK, Piris J, Truelove SC: An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2:892–895, 1977
Dew MJ, Harries AD, Evans N, Evans BK, Rhodes J: Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth. Br Med J 287:23–24, 1983
Baron JH, Connel AM, Lennard-Jones JE, Avery Jones F: Sulphasalazine and salicylazosulfadimidine in ulcerative colitis. Lancet 1:1094–1096, 1962
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hawkey, C.J., Boughton-Smith, N.K. & Whittle, B.J.R. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Digest Dis Sci 30, 1161–1165 (1985). https://doi.org/10.1007/BF01314051
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01314051